Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:GRWCOTCMKTS:MSRTOTCMKTS:NMUSOTCMKTS:TRTC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRWCGrow Capital$0.30+50.0%$0.23$0.01▼$0.42$45.46M25.141,749 shs944 shsMSRTMassRoots$0.19+1.9%$0.20$0.02▼$0.09$96.83M2.451.06 million shs478,932 shsNMUSNemus Bioscience$0.00$0.05▼$0.74$87.04M-0.04377,395 shs1.00 million shsTRTCUnrivaled Brands$0.68+0.1%$0.74$0.06▼$0.82$159.69M2.32.06 million shs488 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRWCGrow Capital0.00%+50.00%+50.00%-0.03%+25.00%MSRTMassRoots0.00%+2.05%+7.55%-20.02%-89.06%NMUSNemus Bioscience0.00%0.00%0.00%0.00%0.00%TRTCUnrivaled Brands0.00%+8.21%-2.46%-26.58%+17.72%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGRWCGrow CapitalN/AN/AN/AN/AN/AN/AN/AN/AMSRTMassRootsN/AN/AN/AN/AN/AN/AN/AN/ANMUSNemus BioscienceN/AN/AN/AN/AN/AN/AN/AN/ATRTCUnrivaled BrandsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGRWCGrow Capital 0.00N/AN/AN/AMSRTMassRoots 0.00N/AN/AN/ANMUSNemus Bioscience 0.00N/AN/AN/ATRTCUnrivaled Brands 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGRWCGrow Capital$2.66M17.09N/AN/AN/A∞MSRTMassRoots$10K9,682.50N/AN/A($0.08) per share-2.42NMUSNemus BioscienceN/AN/AN/AN/A($0.12) per shareN/ATRTCUnrivaled Brands$14.29M11.17N/AN/A$0.30 per share2.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGRWCGrow Capital-$1.30MN/A0.00∞N/AN/AN/AN/AN/AMSRTMassRoots-$14.71MN/A0.00∞N/AN/A-139.45%N/AN/ANMUSNemus Bioscience-$19.19MN/A0.00N/AN/AN/AN/A-924.42%N/ATRTCUnrivaled Brands-$30.12MN/A0.00∞N/A-161.97%-25.39%-13.86%N/ALatest GRWC, TRTC, MSRT, and NMUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q3 2025GRWCGrow CapitalN/A-$0.01N/A-$0.01N/A$0.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGRWCGrow CapitalN/AN/AN/AN/AN/AMSRTMassRootsN/AN/AN/AN/AN/ANMUSNemus BioscienceN/AN/AN/AN/AN/ATRTCUnrivaled BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGRWCGrow CapitalN/AN/AN/AMSRTMassRootsN/AN/AN/ANMUSNemus BioscienceN/A0.120.12TRTCUnrivaled Brands0.061.411.34Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGRWCGrow CapitalN/AMSRTMassRoots22.09%NMUSNemus BioscienceN/ATRTCUnrivaled Brands0.04%Insider OwnershipCompanyInsider OwnershipGRWCGrow Capital43.90%MSRTMassRoots6.05%NMUSNemus Bioscience2.70%TRTCUnrivaled Brands6.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGRWCGrow Capital9151.52 million85.00 millionNot OptionableMSRTMassRoots90499.87 million469.63 millionNot OptionableNMUSNemus Bioscience11133.91 millionN/ANot OptionableTRTCUnrivaled Brands330233.88 millionN/ANot OptionableGRWC, TRTC, MSRT, and NMUS HeadlinesRecent News About These CompaniesUnrivaled Brands (OTCMKTS:TRTC) Stock Price Passes Below 200-Day Moving Average - What's Next?June 28 at 4:07 AM | marketbeat.comUnrivaled Brands (OTCMKTS:TRTC) Shares Cross Below 200-Day Moving Average - What's Next?June 19, 2025 | marketbeat.comUnrivaled Brands (OTCMKTS:TRTC) Share Price Crosses Below 200-Day Moving Average - Time to Sell?June 11, 2025 | marketbeat.comUnrivaled Brands (OTCMKTS:TRTC) Stock Crosses Below 200 Day Moving Average - Should You Sell?June 3, 2025 | marketbeat.com3 things WNBA could learn from Unrivaled’s inaugural season, explainedMarch 21, 2025 | msn.comTTC Tour Brands Offers an Unrivaled 3,700+ Guaranteed Departures for 2025March 7, 2025 | msn.comThe Power of Partnership: Unrivaled x Icy HotFebruary 13, 2025 | thesource.comTUnrivaled offers safer alternative to overseas play for Phoenix Mercury stars, WNBA playersJanuary 29, 2025 | bizjournals.comUnrivaled Reveals 1v1 Tournament Participants and RulesJanuary 29, 2025 | msn.comSamsung Galaxy Continues to Push Boundaries - Becoming the Presenting and Official Technology Partner of UnrivaledJanuary 8, 2025 | tmcnet.comThis Week in Women’s Basketball: The countdown is on for UnrivaledJanuary 5, 2025 | msn.comUnrivaled’s list of high-profile partnerships continues to growJanuary 3, 2025 | msn.comUnrivaled up to 36 players after beating financial expectationsNovember 1, 2024 | msn.comUnrivaled makes Clark significant offer to joinNovember 1, 2024 | sportsbusinessjournal.comSUnrivaled in wait-and-see mode amid Caitlin Clark offerOctober 31, 2024 | clutchpoints.comCTNT Sports and Unrivaled sign multi-year media partnershipOctober 17, 2024 | msn.comTNT to air Unrivaled women’s basketball gamesOctober 17, 2024 | msn.comTNT Sports Gets Into Women’s Basketball, Inks Rights Deal With Startup League UnrivaledOctober 17, 2024 | msn.comTNT Sports Secures Multi-Year Partnership with Unrivaled for Exclusive Game CoverageOctober 17, 2024 | thesource.comTUnrivaled nets TNT Sports media rights dealOctober 17, 2024 | sportspromedia.comSTNT Sports Joins Women's Basketball With Unrivaled Rights DealOctober 17, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGRWC, TRTC, MSRT, and NMUS Company DescriptionsGrow Capital OTCMKTS:GRWC$0.30 +0.10 (+50.00%) As of 06/27/2025 11:09 AM EasternGrow Capital, Inc. operates in the financial technology sector. It provides software, technology, and services to financial services firms and advisors. The company's software suite delivers customized back office compliance, multi-pay commission processing, and new client application submission system, as well as digital engagement marketing services centric to financial services. It also provides software customization, licensing, and subscription service contracts, as well as ongoing customization and maintenance services; and ad hoc services, including web hosting, website development, and other complementary professional services. The company was incorporated in 1999 and is based in Henderson, Nevada.MassRoots OTCMKTS:MSRT$0.19 +0.00 (+1.95%) As of 06/27/2025MassRoots, Inc. engages in the development and provision of social media network for the cannabis community. It offers WeedPass, a rewards program which enables consumers to earn tickets to movies, sporting events, and festivals by shopping at participating dispensaries. The company was founded by Isaac Dietrich, Stewart Fortier, Tyler Knight, and Hyler Fortier in April 2013 and is headquartered in Denver, CO.Nemus Bioscience OTCMKTS:NMUSNemus Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; NB1222 used for treating chemotherapy induced nausea and vomiting; and NB3111 for the treatment of methicillin-resistant staphylococcus aureus. Its products under research comprise NB2111 for use in treating chemotherapy induced peripheral neuropathy; and NB2222 for the treatment of uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy. Nemus Bioscience, Inc. has a license agreement with the University of Mississippi to research, develop, and commercialize products for the treatment of infectious diseases. The company was founded in 2012 and is headquartered in Costa Mesa, California.Unrivaled Brands OTCMKTS:TRTC$0.68 +0.00 (+0.15%) As of 06/27/2025Terra Tech Corp. cultivates, produces, and retails medical and adult use cannabis products. The company also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities in California and Nevada under the Blüm name in California and Nevada. Terra Tech Corp. was founded in 2010 and is based in Santa Ana, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
